[go: up one dir, main page]

DE3770937D1 - Tablette zur pharmazeutischen anwendung sukzessiver freisetzung. - Google Patents

Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.

Info

Publication number
DE3770937D1
DE3770937D1 DE8787119166T DE3770937T DE3770937D1 DE 3770937 D1 DE3770937 D1 DE 3770937D1 DE 8787119166 T DE8787119166 T DE 8787119166T DE 3770937 T DE3770937 T DE 3770937T DE 3770937 D1 DE3770937 D1 DE 3770937D1
Authority
DE
Germany
Prior art keywords
casing
layer
tablet
pharmaceutical use
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787119166T
Other languages
English (en)
Inventor
Manna Aldo La
Paolo Colombo
Ubaldo Conte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAIDEA Srl
Original Assignee
PHARMAIDEA Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAIDEA Srl filed Critical PHARMAIDEA Srl
Application granted granted Critical
Publication of DE3770937D1 publication Critical patent/DE3770937D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8787119166T 1987-01-13 1987-12-23 Tablette zur pharmazeutischen anwendung sukzessiver freisetzung. Expired - Fee Related DE3770937D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19064/87A IT1201136B (it) 1987-01-13 1987-01-13 Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive

Publications (1)

Publication Number Publication Date
DE3770937D1 true DE3770937D1 (de) 1991-07-25

Family

ID=11154233

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787119166T Expired - Fee Related DE3770937D1 (de) 1987-01-13 1987-12-23 Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.

Country Status (10)

Country Link
US (1) US4865849A (de)
EP (1) EP0274734B1 (de)
JP (1) JPS63190822A (de)
KR (1) KR880008805A (de)
AT (1) ATE64528T1 (de)
AU (1) AU610112B2 (de)
DE (1) DE3770937D1 (de)
ES (1) ES2031491T3 (de)
IT (1) IT1201136B (de)
NZ (1) NZ223160A (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions
SE464275B (sv) * 1989-07-31 1991-04-08 Aagerup Bengt Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
US5133892A (en) * 1990-10-17 1992-07-28 Lever Brothers Company, Division Of Conopco, Inc. Machine dishwashing detergent tablets
US5674530A (en) * 1991-01-31 1997-10-07 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
US5387421A (en) * 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5976571A (en) * 1991-01-31 1999-11-02 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
DK0521388T3 (da) * 1991-07-01 1995-09-11 Gergely Gerhard Fremgangsmåde til fremstilling af et farmaceutisk præparat med mindst to forskellige aktivstoffer samt anvendelsen af et sådant præparat
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
ATE234611T1 (de) * 1993-04-20 2003-04-15 Tsrl Inc Mehrstufiges arzneistoffabgabesystem
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
GB9401894D0 (en) 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
AU746091B2 (en) * 1995-04-03 2002-04-18 Chugai Seiyaku Kabushiki Kaisha Sucralfate containing pharmaceutical composition
KR19980703526A (ko) * 1995-04-03 1998-11-05 나가야마오사무 수크랄페이트 함유 제제 조성물
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
EP2020229A1 (de) 1998-11-02 2009-02-04 Elan Pharma International Limited Mehrpartikelmodifizierte Freisetzungszusammensetzung
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
CN102716101A (zh) 1999-10-29 2012-10-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
US20040137062A1 (en) * 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
NZ532097A (en) 2001-09-28 2006-02-24 Mcneil Ppc Inc Dosage forms having an inner core and outer shell
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
CA2486794A1 (en) * 2002-06-04 2003-12-11 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
DE10248652A1 (de) * 2002-10-18 2004-04-29 Solvay Interox Gmbh Verfahren zur Herstellung von staubfreien Erdalkaliperoxiden
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
DE202005020881U1 (de) 2004-08-23 2006-12-07 PEJO Iserlohn Heilmittel und Diät GmbH & Co. KG Psychostimulans enthaltende pharmazeutische Zusammensetzung
EP1830791B1 (de) * 2004-11-19 2014-09-10 GlaxoSmithKline LLC Pharmazeutisches produkt
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20090069275A1 (en) * 2006-02-17 2009-03-12 Rocca Jose G Low flush niacin formulation
SG10201503411QA (en) 2006-08-03 2015-06-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
US8128460B2 (en) * 2006-09-14 2012-03-06 The Material Works, Ltd. Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell
EP2101713A1 (de) * 2006-12-05 2009-09-23 Universita' Degli Studi Di Parma Neue module, neue anordnungssets und neue anordnungen für die kontrollierte freisetzung von substanzen
CN105534936B (zh) * 2007-08-13 2020-07-31 Ohemo 生命科学股份有限公司 抗滥用药物、使用方法和制备方法
BRPI0818286A2 (pt) 2007-10-12 2020-08-11 Takeda Pharmaceuticals North America, Inc. métodos de tratamento de distúrbios gastrointestinais independente da ingestão de alimento.
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
CA2749646A1 (en) * 2009-01-26 2010-07-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
JP5698683B2 (ja) 2009-03-09 2015-04-08 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 治療薬のパルス放出組成物
CA2780347A1 (en) * 2009-12-07 2011-06-16 Mcneil-Ppc, Inc. Partial dip coating of dosage forms for modified release
JP5914701B2 (ja) 2012-02-22 2016-05-11 デュシネイ・インコーポレイテッド ドキシラミンおよびピリドキシン、ならびに／またはその代謝物もしくは塩の製剤
GB201303781D0 (en) 2013-03-04 2013-04-17 Gauthier Pierre Pascal Oral timer device and method of using same
US20140275149A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
SG11201600122RA (en) 2013-07-22 2016-02-26 Duchesnay Inc Composition for the management of nausea and vomiting
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
WO2017193099A1 (en) * 2016-05-05 2017-11-09 Xiaoling Li Controlled release dosage form
CN116406260A (zh) * 2020-11-30 2023-07-07 Ss制药株式会社 含有布洛芬的固体制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (de) * 1955-12-22
FR2100858B1 (de) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
JPS5333885Y2 (de) * 1974-08-01 1978-08-21
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4753790A (en) * 1986-12-16 1988-06-28 Warner-Lambert Company Sorbitol coated comestible and method of preparation
US4786911A (en) * 1987-11-10 1988-11-22 The Boeing Company Apparatus for circularly polarized radiation from surface wave transmission line

Also Published As

Publication number Publication date
EP0274734A1 (de) 1988-07-20
AU1017988A (en) 1988-07-14
KR880008805A (ko) 1988-09-13
US4865849A (en) 1989-09-12
AU610112B2 (en) 1991-05-16
EP0274734B1 (de) 1991-06-19
JPS63190822A (ja) 1988-08-08
NZ223160A (en) 1990-09-26
IT8719064A0 (it) 1987-01-13
IT1201136B (it) 1989-01-27
ATE64528T1 (de) 1991-07-15
ES2031491T3 (es) 1992-12-16

Similar Documents

Publication Publication Date Title
DE3770937D1 (de) Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
DE3778223D1 (de) Biologisch erodierbares system mit gesteuerter freisetzung des arzneiwirkstoffes.
KR900701325A (ko) 속방성 구강 투여용 정제
SE8703034L (sv) Oralt terapeutiskt system med systemisk verkan
NO915043D0 (no) Osmoseanordning for kontrollert avgivelse av et nyttig middel
KR880013586A (ko) 고체상태성질을 가진 제거 가능한 기질을 포함하는 투약기
DE3773070D1 (de) Arzneimittel mit verzoegerter freigabe in oraler dosisform.
DE3878361D1 (de) Umhuellte retardformen.
ATE65023T1 (de) Pharmazeutische mittel.
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
ES2009346A6 (es) Procedimiento de preparacion de composiciones farmaceuticas que contienen polipeptidos hidroinsolubles.
ATE167390T1 (de) Vorrichtung zur kontrollierten freigabe
IE882898L (en) Solubility modulated drug delivery device
PT96921B (pt) Dispositivo de libertacao intermitente
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
DE3688355D1 (de) Fester koerper mit ueberzogenem kern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee